Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 study of S-217622 in healthy adults
jRCT2031210202Phase 1Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of ensitrelvir in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Shionogi & Co., Ltd. Primary endpoints: Safety and tolerability, Pharmacokinetics of S-217622 in SAD, MAD, W-MAD, and elderly parts and 2 more. Started Jul 2021; status: completed.
02
Drugs
ensitrelvir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on jRCT2031210202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031210202.